Brief: Mochida Pharmaceutical signs contract for joint development of sale of gout and hyperuricemia treatment FYU-981 in Japan with FUJIYAKUHIN Co., Ltd.
06/03/2017 06:11
March 6 (Reuters) - Mochida Pharmaceutical Co Ltd 4534.T :
* Says it signed a contract for joint development of sale of
gout and hyperuricemia treatment FYU-981 in Japan with
FUJIYAKUHIN Co., Ltd.
Source text in Japanese: https://goo.gl/V48nlh
Further company coverage: 4534.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com;)(+86 010
62674724;)(Reuters
Messaging:)(shuai.liu.reuters.com@reuters.net))